Summary
The antimicrobial spectrum of lactoferrin (Lf) includes statsis, cidal, cationic, phagocytic, and colonization/decolonization effects on susceptible microorganisms. The selective interaction of Lf with microbial surface seems to play an essential role in regulating many of these events. Lf bound to specific outer membrane (OM) pore-forming proteins (porins) of various enteric bacteria. The magnitude of Lf-microbe interaction showed a direct relationship with the bacterial susceptibility to Lf. Although most bacteria expressed porins, certain strains showed resistance to Lf effects and did not demonstrate specific Lf binding. This Lf “resistance” was attributed to the shielding of porin accessibility by the carbohydrate O-antigenic chains of lipopolysaccharide (LPS). Mutants with progressive deletions in O-side-chain and core polysaccharide demonstrated increased Lf binding and progressive susceptibility to Lf effects. Lf interaction with bacterial surface affected the porin channels in the OM and potentiated the diffusion of antibiotics. Lf also affected the intestinal colonization of Escherichia coli. Lf inhibited the expression of various bacterial fimbriae and also blocked bacterial interaction with host subepithelial matrix components, such as fibronectin, fibrinogen, various collagens, and laminin. Our studies suggested that specific interaction with cell target involved the anion-binding ligands of Lf, followed by coordinate binding and oxidation of Fe2+ to Fe3+ on bacterial surface. This metal transition in the presence of suitable oxygen species seems to fulfill the necessary components of Haber-Weiss reaction and promote a targeted radical generation, with iron (Fe) serving as the Lf prosthetic group on the bacterial surface.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson, B. F., Baker, H. M., Norris, G. E., Rumball, S. V., and Baker, E. N. (1990) Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature 344, 784–788.
Arnold, R. R., Cole, M. F., and McGhee, J. R. (1977) A bactericidal effect for human lactoferrin. Science 197, 263–265.
Arnold, R. R., Russell, J. E., Champion, W. J., and Gauthier, J. J. (1981) Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 32, 655–660.
Arnold, R. R., Russell, J. E., Champion, W. J., Brewer, M., and Gauthier, J. J. (1982) Bactericidal activity of human lactoferrin: differentiation from the stasis of iron depriviation. Infect. Immun. 35, 792–799.
Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M. (1992) Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121, 130–136.
Bennett, R. M. and Davis, J. (1981) Lactoferrin binding to human peripheral blood cells: an interaction with B enriched population of adherent mononuclear cells. J. Immunol. 127, 1211–1216.
Bennett, R. M., Merritt, M. M., and Gabor, G. (1986) Lactoferrin binds to neutrophilic DNA. Br. J. Haematol. 63, 105–117.
Bishop, J. G., Schanbacher, F. L., Fergusson, L. C., and Smith, K. L. (1976) In vitro growth inhibition of mastitis causing coliform bacteria by bovine apo-Lf and reversal of inhibition by citrate and high concentrations of apo-Lf. Infect. Immun. 14, 911–916.
Boxer, L. A., Haak, R. A., Yang, H.-H., Walach, J. B., Whitcomb, J. A., Butterick, C. J., and Baehner, R. L. (1982) Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes. J. Clin. Invest. 70, 1049–1057.
Brock, J. H., Pickering, M. G., McDowall, M. C., and Deacon, A. G. (1983) Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin- and transferrin-bound iron by Escherichia coli. Infect. Immun. 40, 453–459.
Broer, K. H., Dauber, U., Herrmann, W. P., and Hirshhauser, C. (1977) The presence of lactoferrin (SCA) on the human sperm head during in vitro penetration through cervical mucus. IRCS J. Med. Sci. 5, 362.
Bullen, J. J., Rogers, H. J., and Leigh, L. (1972) Iron-binding proteins in milk and resistance to Escherichia coli infections in infants. Br. Med. J. 1, 69–75.
Cox, T. M., Mazurier, J., Spik, G., Montreuil, J., and Peters, T. J. (1979) Iron-binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human small intestine. Biochim. Biophys. Acta 588, 120–128.
Davidson, L. A. and Lönnerdal, B. (1988) Specific binding of lactoferrin to brush-border membranes: ontogeny and effect of glycan chain. Am. J. Physiol. 254, G6580-G6586.
Ellison, R. T., Giehl, T. J., and LaForce, F. M. (1988) Damage of the outer membrane of gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56, 2774–2781.
Erdei, J., Forsgren, A., and Naidu, A. S. (1994) Lactoferrin binds to porins OmpF and OmpC in Escherichia coli. Infect. Immun. 62, 1236–1240.
Gadó, I., Erdei, J., Laszlo, V. G., Pászti, J., Czirók, E., Kontrohr, T., Tóth, I., Forsgren, A., and Naidu, A. S. (1991) Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob. Agents Chemother. 35, 2538–2543.
Gutteberg, T. J., Rokke, O., Jorgensen, T., and Andersson, O. (1988) Lactoferrin as indicator of septicemia and endotoxaemia in pigs. Scand. J. Infect. Dis. 20, 659–667.
Hekman, A. (1971) Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility. Biochim. Biophys. Acta 251, 380–387.
Holmgren, J., Svennerholm, A.-M., and Åhrén, C. (1981) Nonimmuno-globulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae. Infect. Immun. 33, 136–141.
Horwitz, D. A., Bakke, A. C., Abo, W., and Nichiya, K. (1984) Monocyte and NK cell cytotoxic activity of human adherent cell preparations. Discriminating effects of interferon and lactoferrin. J. Immunol. 132, 2370–2376.
Hutchens, T. W., Magnuson, J. S., and Yip, T. T. (1989) Rapid purification of porcine colostral whey lactoferrin by affinity chromatography on single-stranded DNA-agarose. Characterization, amino acid composition, and N-terminal amino acid sequence. Biochim. Biophys. Acta 999, 323–329.
Izhar, M., Nuchamowitz, Y., and Mirelman, D. (1982) Adherence of Shigella flexneri to guinea pig intestinal cells is mediated by a mucosal adhesin. Infect. Immun. 35, 1110–1118.
Konisky, J. (1982) Colicins and other bacteriocins with established modes of action. Ann. Rev. Microbiol. 36, 125–144.
Legrand, D., Mazurier, J., Aubert, J.-R, Loucheux-Lefebvre, M.-H., Montreuil, J., and Spik, G. (1986) Evidence for interactions between the 30 kD N- and 50-kD C-terminal tryptic fragments of human lactotransferrin. Biochem. J. 236, 839–844.
Lima, M. R and Kierszenbaum, R (1987) Lactoferrin effects on phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J. Immunol. 139, 1647–1652.
Line, W. F., Sly, D. A., and Bezkrovainy, A. (1976) Limited cleavage of human lactoferrin with pepsin. Int. J. Biochem. 7, 203–208.
Masson, P. L. and Heremans, J. R (1968) Metal-combining properties of human lactoferrin (red milk protein). I. The involvement of bicarbonate in the reaction. Eur. J. Biochem. 6, 579–584.
Naidu, A. S. and Arnold, R. R. (1994) Lactoferrin interaction with Salmonellae potentiates antibiotic susceptibility in vitro. Diagn. Microbiol. Infect. Dis. 20, 69–75.
Naidu, S. S., Erdei, J., Czirók, E., Kalfas, S., Gadó, I., Thorén, A., Forsgren, A., and Naidu, A. S. (1991) Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. Acta Pathol. Microbiol. Immunol. Scand. 99, 1142–1150.
Naidu, S. S., Svensson, U., Kishore, A. R., and Naidu, A. S. (1993) Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob. Agents. Chemother. 37, 240–245.
Oram, J. D., and Reiter, B. (1968) Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim. Biophys. Acta 170, 351–365.
Roberts, A. K., Chierici, R., Sawatzki, G., Hill, M. J., Volpato, S., and Vigi, V. (1992) Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paedriatr. 81, 119–124.
Schryvers, A. B. and Morris, L. J. (1988) Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect. Immun. 56, 1144–1149.
Tigyi, Z., Kishore, A. R., Maeland, J., Forsgren, A., and Naidu, A. S. (1992) Lactoferrin-binding proteins in Shigella flexneri. Infect. Immun. 60, 2619–2626.
van Snick, J. L., Masson, R L., and Heremans, J. R (1974) The involvement of lactoferrin in the hyposideraemia of acute inflammation. J. Exp. Med. 140, 1068–1084.
Yamauchi, K., Tomita, M., Giehl, T. J., and Ellison, R. T., III (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61, 719–728.
Zagulski, T., Lipinski, P., Zagulska, A., Broniek, S., and Jarzabek, Z. (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70, 697–704.
Zhao, J. and Hutchens, T. W. (1994) Proposed mechanisms for the involvement of lactoferrin in hydrolysis of nucleic acids, in Lactoferrin Structure and Function (Hutchens, T. W., Rumball, S., and Lönnerdal, B., eds.), Plenum, New York.
Zou, S., Magura, C. E., and Hurley, W. L. (1992) Heparin-binding properties of lactoferrin and lysozyme. Comp. Biochem. Physiol. 103B, 889–895.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this chapter
Cite this chapter
Naidu, A.S., Arnold, R.R. (1997). Influence of Lactoferrin on Host-Microbe Interactions. In: Hutchens, T.W., Lönnerdal, B. (eds) Lactoferrin. Experimental Biology and Medicine, vol 28. Humana Press. https://doi.org/10.1007/978-1-4612-3956-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3956-7_17
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8439-0
Online ISBN: 978-1-4612-3956-7
eBook Packages: Springer Book Archive